Skip to main content
. 2024 Jun 25;12(7):709. doi: 10.3390/vaccines12070709

Table 1.

Diseases and clinical conditions associated with AHA (adapted from AICE Recommendations 2020).

Diseases or Clinical Conditions Characteristics
Oncologic diseases Multiple myeloma, lymphomas, monoclonal gammopathy of uncertain significance (MGUS), myelofibrosis, myelodysplasia
Rheumatic diseases Rheumatoid arthritis, systemic lupus erythematosus, Sjogren’s syndrome, Goodpasture’s syndrome, temporal arteritis, myasthenia gravis, thyroiditis, multiple sclerosis
Infectious diseases SARS-CoV-2, Epstein Barr virus, hepatitis B/C viruses, Human Immunodeficiency virus
Dermatological diseases Psoriasis, pemphigus
Pregnancy or Puerperium Within 1-4 months of delivery or miscarriage
Drugs Some beta-lactam antibiotics, chloramphenicol, sulfonamides, clopidogrel, nonsteroidal anti-inflammatory drugs (NSAIDs), fludarabine, interferon alpha
Other diseases Asthma, chronic obstructive pulmonary disease, acute hepatitis